Skip to main content
. 2012 Nov-Dec;32(6):636–644. doi: 10.3747/pdi.2011.00137

Figure 7.

Figure 7

— The mixed model shows that, in patients using icodextrin (ICO), the mass transfer coefficient of creatinine (MTCcr) was lower in the subsequent year, although MTCcr values in those patients had been higher at baseline. During years 2 and 3, patients on ICO showed a significant decrease in MTCcr relative to baseline.